ORIGINAL RESEARCH-PHARMACOTHERAPY: Successful Withdrawal of Oral Long‐Acting Nitrates to Facilitate Phosphodiesterase Type 5 Inhibitor Use in Stable Coronary Disease Patients with Erectile Dysfunction

Oral nitrates can be discontinued in the presence of continuing beta‐blockade and/or calcium antagonist therapy in stable coronary disease patients with ED to allow for the safe use of PDE5 inhibitors.